Patents

HemoCue prevails in patent infringement suit over hemoglobin testing product

Published in Blood Weekly, April 13th, 2006

For more than 2 years, HemoCue, AB, and EKF-diagnostics, GmbH, a company in Magdeburg, Germany, have been involved in a patent infringement suit. The Dusseldorf (Germany) District Court where the case has been tried, announced its ruling on March 9, 2006, finding the EKF product infringes HemoCue's patent for hemoglobin testing, registered in 1995.

The product, with near-worldwide patent protection, is a Swedish invention and an established standard in near-patient hemoglobin testing globally. From a single drop of capillary blood, the product determines the concentration of hemoglobin - a test used to diagnose acute blood loss, detect anemia, and screen blood...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2006-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry